ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-tre
While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for H
| Condition(s) | HIV, Cervical Cancer |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for HIV care and treatment programs in Nigeria to integrate cervical cancer screening and treatment and conduct a cluster randomized, hybrid type III trial design to assess the comparative effectiveness of a Core set of implementation strategies versus a Core+ (enhanced) set of implementation strategies to implement cervical cancer screening, onsite treatment, referral and referral completion, treatment, and retention in care among WLHIV. The overarching goal is to improve the hea |
| Who can participate | Inclusion Criteria: * Women living with HIV Exclusion Criteria: \- |
| Ages | 25 Years to 64 Years |
| Sex | Female |
| Lead sponsor | University of California, San Diego |
| Locations | La Jolla, California, United States; Enugu, Enugu State, Nigeria |
| Start date | 2023-11-13 |
| NCT ID | NCT06128304 |
| Official listing | https://clinicaltrials.gov/study/NCT06128304 |